Type 2 Diabetes with Autonomic Neuropathy
Metabolic
Type 2 Diabetes with Autonomic Neuropathy is treated with 2 medications in our database, including METOCLOPRAMIDE, METOCLOPRAMIDE hydrochloride. 2 of these have manufacturer assistance programs available to help reduce out-of-pocket costs. Medications are manufactured by ANI, "ANI # Explanation: Metoclopramide hydrochloride is a gastrointestinal medication originally developed by A.H. Robins (later acquired by Wyeth/Pfizer). The current rights to the brand-name version, **Reglan** (the reference listed drug for the tablet form), are held in the United States by **ANI Pharmaceuticals**. While other companies like Hikma hold the rights to the injectable form and various manufacturers produce generic versions, ANI is the primary owner of the oral brand rights. Following the instruction to provide only the core company name and remove suffixes like ""Pharmaceuticals"" or ""Inc"", the result is **ANI**.". Patients and caregivers can find copay cards, patient assistance programs, and travel grants for Type 2 Diabetes with Autonomic Neuropathy treatment below.
What help exists for Type 2 Diabetes with Autonomic Neuropathy
2
drugs indexed
1
with copay cards
1
with patient assistance
0
open travel grants
Every item below links to the manufacturer's or charity's own portal. RxCopays does not take referral fees.
Drugs used to treat Type 2 Diabetes with Autonomic Neuropathy
2 totalMETOCLOPRAMIDE hydrochloride
Metoclopramide Hydrochloride · ANI # Explanation: Metoclopramide hydrochloride is a gastrointestinal medication originally developed by A.H. Robins (later acquired by Wyeth/Pfizer). The current rights to the brand-name version, **Reglan** (the reference listed drug for the tablet form), are held in the United States by **ANI Pharmaceuticals**. While other companies like Hikma hold the rights to the injectable form and various manufacturers produce generic versions, ANI is the primary owner of the oral brand rights. Following the instruction to provide only the core company name and remove suffixes like "Pharmaceuticals" or "Inc", the result is **ANI**.
METOCLOPRAMIDE
metoclopramide · ANI
🎟💙
🎟 = copay card · 💙 = patient assistance program
Prior authorization patterns for Type 2 Diabetes with Autonomic Neuropathy drugs
Aggregated from CMS SPUF + commercial PBM formularies. Specific rules vary by plan; confirm with your insurer.
| Payer | PA | Step therapy | Copay tier |
|---|---|---|---|
— Medicare Part D | — | — | — |
— Medicare Part D | — | — | — |
— Medicare Part D | — | — | — |
— Medicare Part D | — | — | — |